Not available
Quote | KKR & Co. Inc. Class A (NYSE:KKR)
Last: | $96.77 |
---|---|
Change Percent: | -0.46% |
Open: | $98.42 |
Close: | $96.77 |
High: | $98.55 |
Low: | $95.98 |
Volume: | 3,629,015 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | KKR & Co. Inc. Class A (NYSE:KKR)
2024-04-24 15:44:01 ET More on KKR & Co. KKR: Excellent Market Position In Japan, Fed Rates Are A Short-Term Headwind KKR & Co. Follows Berkshire Hathaway KKR to acquire Swedish pharma firm Immedica KKR targets adjusted EPS of $15.00 in 10 years or le...
2024-04-24 14:30:32 ET More on Apollo Global Management Apollo Global Management Is Cheap No More But It Will Not Stop The Stock Apollo Global Management: Shares Have Become Fairly Valued UBS, Apollo's Atlas SP end transition agreement, another milestone in Credit Su...
Message Board Posts | KKR & Co. Inc. Class A (NYSE:KKR)
Subject | By | Source | When |
---|---|---|---|
$KKR Price trading | a surfer | investorshub | 07/05/2023 11:30:28 AM |
best news of the day | LOYS | investorshub | 07/01/2023 7:15:06 AM |
where is the squeeze? | Hitman970 | investorshub | 06/29/2023 5:52:07 AM |
Price trading | Koan | investorshub | 06/26/2023 5:22:36 PM |
$KKR What do you make of this? | LOYS | investorshub | 06/26/2023 5:38:40 AM |
News, Short Squeeze, Breakout and More Instantly...
KKR & Co. Inc. (NYSE:KKR) shares are trading lower on Wednesday. European Union antitrust regulators are inquiring competitors and cl...
In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze compani...
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Existing owner, Nordic healthcare in...